100+ CEOs, Biopharma Leaders Sound Alarm on ‘Catastrophic’ Health Cuts

In an open letter addressing the Trump administration’s proposed budget cuts to HHS, the executives urged Congress to continue “robust federal funding” for scientific research, which they say will help maintain U.S. biotech leadership globally.

Scroll to Top